When do we remain with the devil we know (the vitamin K antagonists) … in atrial fibrillation?
Transatlantic Dialogues on Controversies in Contemporary Cardiology 2016, RomeAug. 28, 2016 - Rome, Italy - Raffaele De Caterina, MD – Chieti, Italy
As part of a shared session at the Brigham and Women's Hospital and PACE-cme Transatlantic Dialogue, Raffaele De Caterina considers various forms of valvular disease that have been seen as a criterium not to use NOAC therapy for stroke prevention. Mitral stenosis may be an example that merits further study, as treatment may be indicated and safe.
This lecture is part of a special educational symposium exploring controversies in cardiovascular risk management and compared and contrasted best common practices and guidelines on both sides of the Atlantic. American and European experts discussed novel insights from basic and translational cardiovascular science in the context of ongoing and future clinical studies
The program is an initiative of research leaders from the Brigham and Women’s Hospital, Boston, USA in collaboration with the PACE foundation.
Raffaele De Caterina, MD – Professor of Cardiology G. d’Annunzio University in Chieti, Italy
Faculty did not receive an honorarium for their lectures